News

Video interview in the lab of Ranjit S. Bindra, MD, PhD, a physician-scientist at Yale School of Medicine and co-director of the Yale Brain Tumor Center at Smilow Cancer Hospital.

The Connecticut Breast Health Initiative has announced the recipients of the 2025 Research and Education Grants, and recognized individuals receiving CTBHI Awards of Distinction for their efforts in support of the organization and their work raising funds to support breast cancer research.

Ketamine, long used as an anesthetic or illegal party drug, is being combined with psychotherapy to treat severe depression and post-traumatic stress.

An intensive two-day Yale Cancer Research symposium, dedicated to advancing cancer science through innovation and strengthening partnerships between Yale University and Historically Black Colleges and Universities (HBCUs), brought together researchers from multiple disciplines this week.

October is Breast Cancer Awareness Month. Dr. Eric Winer, the director of Yale Cancer Center and president and physician-in-chief of Smilow Cancer Hospital, discussed the latest advancements in breast cancer research, treatment, and prevention with News 8.

A brain network linked to social attention is functional in newborns, a Yale study finds. It may underlie some of the social vulnerabilities associated with autism.

Treatment-resistant does not mean untreatable. Discover the evidence-based options for coping with this form of depression.

The Office of Research on Women’s Health and National Institute on Alcohol Abuse and Alcoholism has awarded a U54 Specialized Center of Research Excellence (SCORE) grant to the Yale-SCORE investigative team.

Fluctuations in brain activity increase until mid-adolescence. Deviations from this trajectory are linked to worse executive functioning.